Tag: SEC

DNB Financial Corporation Receives All Required Approvals to Acquire East River Bank

DOWNINGTOWN, Pa., Sept. 14, 2016 (GLOBE NEWSWIRE) — DNB Financial Corporation (“DNB”) (NASDAQ:DNBF), the parent company of DNB First, National Association, today announced that it has obtained all required approvals necessary for DNB to consummate its acquisition of East River Bank, Philadelphia, Pennsylvania (“East River”). Approvals included DNB and East River shareholder approvals, and regulatory approval from the Office of the Comptroller of the Currency, the Board of Governors of the Federal Reserve System and the Pennsylvania Department of Banking. When the combination of the two organizations is completed, DNB will have approximately $1.1 billion in assets, $764 million in

Feature Box

Aspen Group Reports 62% Increase in Revenue for First Quarter Fiscal 2017, Gross Margin Increases 1,500 Basis Points

NEW YORK, Sept. 14, 2016 (GLOBE NEWSWIRE) — Aspen Group, Inc. (OTCQB:ASPU) (“Aspen”), a nationally accredited online post-secondary education company (Aspen University), today announced financial results for its 2017 fiscal first quarter ended July 31, 2016. The Company will host a conference call to discuss its financial results on Wednesday, September 14, 2016, at 5:00 p.m. (ET).  “Aspen just recorded its highest enrollment quarter in the company’s history, all during our seasonally slowest summer period, which is a testament to the strength of our ‘pay-as-you-go,’ debtless education business model.  Our conversion rate increased to a record 11.2% in the quarter

Apigee Announces Fourth Quarter and Fiscal 2016 Results

SAN JOSE, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) — Apigee® (NASDAQ:APIC), the API company, today announced financial results for its fourth quarter and fiscal year ended July 31, 2016. Fiscal Year 2016 For FY 16, Apigee reported total revenue of $92.0 million, up 34% compared to $68.6 million in FY 15.  Apigee reported FY 16 product revenue (defined as license revenue plus subscription and support revenue) of $75.3 million, up 46% compared to $51.6 million in FY 15. Apigee reported FY 16 GAAP gross margin of 70.1%, up from 63.6% in FY 15, and non-GAAP gross margin of 71.8% compared to

Immune Design Announces Proposed Public Offering of Common Stock

SEATTLE and SOUTH SAN FRANCISCO, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) — Immune Design Corp. (Nasdaq:IMDZ) announced today that it plans to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the proposed offering are to be sold by Immune Design. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering. Jefferies LLC, Leerink Partners LLC and Wells Fargo Securities, LLC are acting as joint book-running managers for the

U.S. Global Investors Reports Financial Results for Fiscal Year 2016

San Antonio, TX, Sept. 14, 2016 (GLOBE NEWSWIRE) — For Immediate Release U.S. Global Investors Reports Financial Results for Fiscal Year 2016 Continuing Dividends and Share Repurchase Program ************************************************************************ SAN ANTONIO-September 14, 2016 –U.S. Global Investors, Inc. (NASDAQ: GROW), a boutique registered investment advisory firm with longstanding experience in global markets and specialized sectors, today reported a net loss of $3.7 million, or $(0.24) per share, on operating revenues of $5.5 million for the fiscal year ended June 30, 2016. For the fiscal year 2015, U.S. Global Investors recorded a net loss of $4.0 million, or $(0.26) per share, on

Nasdaq Hearings Panel Grants Extension of Exception for Continued Listing of United Development Funding IV Shares

GRAPEVINE, Texas, Sept. 14, 2016 (GLOBE NEWSWIRE) — United Development Funding IV (“UDF IV” or the “Trust”) (NASDAQ:UDF) today announced that the Nasdaq Hearings Panel (the “Panel”) has granted an extension of the exception previously granted for continued listing of the Trust’s common shares on The NASDAQ Stock Market (“Nasdaq”).   The Trust’s continued listing is subject to the condition that, on or before October 17, 2016, the Trust become current in its periodic filings with the Securities and Exchange Commission (the “SEC”).  The Trust must also be able to demonstrate that it satisfies all other quantitative and qualitative requirements for

PDC Energy Closes Common Stock and Convertible Senior Notes Offerings

DENVER, Sept. 14, 2016 (GLOBE NEWSWIRE) — PDC Energy, Inc. (“PDC” or the “Company”) (Nasdaq:PDCE) today announced that it has closed its previously announced concurrent underwritten public offerings of (i) 9,085,000 shares of its common stock (the “common stock”), which number of shares includes 1,185,000 shares issued pursuant to the exercise of the underwriters’ overallotment option, and (ii) $200 million aggregate principal amount of its convertible senior notes due 2021 (the “notes”), which aggregate principal amount includes $25 million issued pursuant to the exercise of the underwriters’ overallotment option. The net proceeds from the common stock offering were approximately $558.8

iSectors, LLC to Ring The Nasdaq Stock Market Opening Bell

ADVISORY, Sept. 14, 2016 (GLOBE NEWSWIRE) —              What: iSectors, LLC, a manager of a suite of exchange-traded fund (ETF)-based asset allocation models, will visit the Nasdaq MarketSite in Times Square in celebrating the recent debut its flagship iSectors® Post-MPT Growth ETF (Nasdaq:PMPT). The actively-managed ETF aims to optimize investor return and minimize the downside risk. In honor of the occasion, Charles H. Self III, Chief Operating Officer and Chief Investment Officer of iSectors and Portfolio Manager for PMPT, will ring the Opening Bell.  Where:Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast

Feature Box

PetLife Pharmaceuticals Continues Execution of its Vitalzul TM Business Plan with start of Proof of Concept studies; Provides Updates

Hancock, MD, Sept. 14, 2016 (GLOBE NEWSWIRE) — Hancock, MD – PetLife Pharmaceuticals, Inc. (OTC QB: PTLFD) (the “Company”), a developer of Vitalzul™, a new generation of high potency veterinary cancer medications and nutraceuticals for pets, announces plans to begin its Proof of Concept study as part of its pre-INAD (Investigational New Animal Drug) program. The study will be undertaken under contract by InnoVision Therapeutics. Proof of Concept studies are an early stage of clinical drug development when a compound has shown potential in animal models and early safety testing. These small-scale studies are designed to detect a signal that

Ocean Power Technologies Announces New Contract with the U.S. Department of Defense Office of Naval Research

PENNINGTON, N.J., Sept. 14, 2016 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NASDAQ:OPTT) (“OPT” or “the Company”) announced today that it has been awarded a contract (or “Contract”), valued at nearly $250,000, by the U.S. Department of Defense Office of Naval Research (“ONR”) to conduct the design of a new mass-spring oscillating PowerBuoy for mission critical sensors.  Such a PowerBuoy differs from the current PB3 type in that it is self-contained and has no external moving components. Phase one of the contract scope includes the system design and laboratory testing of a proprietary, self-contained, inertia-based, mass-spring oscillator and power take-off

Rexahn Announces $6 Million Registered Direct Offering

ROCKVILLE, Md., Sept. 14, 2016 (GLOBE NEWSWIRE) — Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN) today announced it has entered into a definitive agreement with institutional investors to purchase 24 million shares of its common stock and warrants exercisable for up to 18 million shares of its common stock for gross proceeds of $6 million.  The shares and warrants are being sold in units, each consisting of one share of common stock and a warrant to purchase 0.75 of a share of common stock, at an offering price of $0.25 per unit. The warrants will be exercisable six months following the date

Gladstone Commercial Corporation Announces $23.9 Million Office Property Acquisition in Fort Lauderdale, FL

MCLEAN, Va., Sept. 14, 2016 (GLOBE NEWSWIRE) — Gladstone Commercial Corporation (NASDAQ:GOOD) (“Gladstone Commercial”) announced today that it acquired a five-story, 119,224 square foot, single-tenant office building located in Fort Lauderdale, FL, for $23.9 million at an average cap rate of 8.3%. The property is leased to Citrix, under a triple-net (or NNN) lease. Citrix, a Fortune 1000 and S&P 500 company with a market capitalization of over $10 billion, provides a complete and integrated portfolio of Workspace-as-a-Service, application delivery, virtualization, mobility, network delivery and file sharing solutions that enables companies to ensure critical systems are securely available to users

International Western Petroleum Completes East Texas Acquisition in Kilgore City

IRVING, Texas, Sept. 14, 2016 (GLOBE NEWSWIRE) — International Western Petroleum, Inc. (OTCQB:INWP), a Texas-based E&P company specializing in the acquisition, development, and exploration of crude oil and natural gas properties, announced today that it has completed an acquisition of a producing oil field in Kilgore, Texas via the Marshall Walden Joint Venture, a partnership with Odyssey Enterprises, LLC. International Western Petroleum is the managing venturer in this joint venture with Odyssey which has financed the joint venture for the lease purchase and optimization of wells located in Kilgore, Texas, in the heart of the famous Woodbine formation. There are

Semtech UHD and HDR Solution Wins Best of Show Award at IBC 2016

CAMARILLO, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) — Semtech Corporation (Nasdaq:SMTC), a leading supplier of analog and mixed-signal semiconductors, won the NewBay Best of Show Award from TV Technology at the International Broadcasting Convention (IBC) 2016 for its newly-announced UHD-SDI retiming cable equalizer and cable driver for next-generation UHD and HDR applications. The award was announced at IBC on September 12. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/9779f5f0-4c55-49bb-98ed-786dd4c91154 The GS12090, announced and demonstrated at the IBC show last week, is the industry’s highest performing, configurable 12G UHD-SDI cable equalizer/cable driver. It is ideally suited for use in applications

Anavex to Participate in Mizuho Therapeutics Conference

NEW YORK, Sept. 14, 2016 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, other central nervous system (CNS) diseases, pain and various types of cancer, today announced that Christopher U. Missling, PhD, President and Chief Executive Officer, will participate in Mizuho Therapeutics Conference on Wednesday, September 21, 2016. The conference will be held at the Langham Hotel in Boston, Massachusetts. Investors interested in attending may contact the conference organizers or Anavex Investor Relations. About Anavex Life Sciences Corp.

Plug Power and Mitsubishi Nichiyu Show Fuel Cell Powered Forklift at Logis Tech Tokyo

LATHAM, N.Y., Sept. 14, 2016 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ:PLUG), a leader in providing energy solutions that change the way the world moves, announces that Mitsubishi Nichiyu Forklift is displaying one of the company’s GenDrive fuel cell systems in its industrial trucks at Logis Tech Tokyo – the culmination of a year of product evaluation and engineering collaboration work by both companies. Mitsubishi Nichiyu will show the Plug Power GenDrive Model 1600 fuel cell in its own class 1 electric forklift truck. The company has been testing the fuel-cell powered forklift truck in Kyoto since June 2016. The

Yappn Signs a Referral Partner Agreement with Startek Co. Ltd.

NEW YORK, Sept. 14, 2016 (GLOBE NEWSWIRE) — Yappn Corp. (“Yappn” or “Company”) (OCTQB:YPPN), a real-time innovative language solutions Company is pleased to announce that it has signed a Referral Partner Agreement with Startek Co. Ltd. (“Startek”). In accordance with the terms of the Agreement, Startek is an authorized referral partner for the purpose of referring prospective customers to Yappn, focused primarily but not limited to, the Japanese market. Atsushi Kajiwara, CEO of Startek stated: “By eliminating the language barrier, businesses can readily reach new markets. Yappn’s solutions give a competitive advantage for companies that want to communicate more effectively

Great Elm Capital Group Proposes Rights Offering

BOSTON, Sept. 14, 2016 (GLOBE NEWSWIRE) — Great Elm Capital Group, Inc. (NASDAQ:GEC), announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed rights offering to holders of its common stock.  If the rights offering is fully subscribed, Great Elm Capital Group expects $45 million of gross proceeds that will be used for general corporate purposes, which may include acquisitions and investments. Upon the effectiveness of the registration statement, Great Elm Capital Group intends to distribute to common stockholders of record as of the record date (which has not yet been determined)

Agios Announces Proposed Offering of Common Stock

CAMBRIDGE, Mass., Sept. 13, 2016 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq:AGIO) today announced that it is offering to sell, subject to market and other conditions, up to $150 million of its common stock in an underwritten public offering. Agios also intends to grant the underwriters a 30-day option to purchase from it up to an additional $22.5 million of shares. All of the shares in the offering are to be sold by Agios. The proceeds of the offering are expected to be used to fund the company’s clinical and research development activities. The offering is subject to market and

Xenon Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Closing of $34.5 Million Public Offering

BURNABY, British Columbia, Sept. 13, 2016 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that the underwriters of the previously announced public offering of its common shares have exercised in full their option to purchase an additional 600,000 common shares, consisting of 450,000 common shares from Xenon and 150,000 common shares from the selling securityholders named in the final prospectus supplement for the offering. The closing of the sale of all common shares occurred today. Gross proceeds from the offering of an aggregate of 3,450,000 common shares by Xenon and the offering of an aggregate of